Regulus Therapeutics Inc.
RGLS
$2.06
$0.126.19%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 75.78M | 87.31M | 94.46M | 97.55M | 23.77M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | 3.49M | 3.23M | 3.18M | 3.01M | 3.01M |
| Prepaid Expenses | 3.02M | 1.09M | 2.63M | 821.00K | 1.34M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 62.00K | 62.00K | 62.00K | 62.00K | 62.00K |
| Total Current Assets | 82.35M | 91.69M | 100.34M | 101.45M | 28.18M |
|
|
|||||
| Total Current Assets | 82.35M | 91.69M | 100.34M | 101.45M | 28.18M |
| Net Property, Plant & Equipment | 1.81M | 2.05M | 2.26M | 2.42M | 2.54M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 25.00K | 25.00K | 27.00K | 30.00K | 33.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 21.00K | 74.00K | -- |
| Total Assets | 84.18M | 93.76M | 104.12M | 114.14M | 30.75M |
|
|
|||||
| Total Accounts Payable | 947.00K | 792.00K | 601.00K | 406.00K | 204.00K |
| Total Accrued Expenses | 5.40M | 4.93M | 3.86M | 2.49M | 4.59M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 781.00K | 764.00K | 747.00K | 1.27M | 2.05M |
| Total Finance Division Other Current Liabilities | 368.00K | -- | 54.00K | 1.52M | 1.67M |
| Total Other Current Liabilities | 368.00K | -- | 54.00K | 1.52M | 1.67M |
| Total Current Liabilities | 7.50M | 6.48M | 5.26M | 5.68M | 8.51M |
|
|
|||||
| Total Current Liabilities | 7.50M | 6.48M | 5.26M | 5.68M | 8.51M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 274.00K | 476.00K | 675.00K | 868.00K | 1.06M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.77M | 6.96M | 5.94M | 6.55M | 9.56M |
|
|
|||||
| Common Stock & APIC | 635.92M | 633.46M | 630.98M | 629.31M | 534.40M |
| Retained Earnings | -559.57M | -546.78M | -532.72M | -521.68M | -513.21M |
| Treasury Stock & Other | 50.00K | 120.00K | -87.00K | -45.00K | -- |
| Total Common Equity | 76.40M | 86.80M | 98.18M | 107.58M | 21.18M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 5.00K | 5.00K | 5.00K | 5.00K | 5.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 5.00K | 5.00K | 5.00K | 5.00K | 5.00K |
|
|
|||||
| Total Common Equity | 76.40M | 86.80M | 98.18M | 107.58M | 21.18M |
| Total Preferred Equity | 5.00K | 5.00K | 5.00K | 5.00K | 5.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 76.41M | 86.81M | 98.18M | 107.59M | 21.19M |
|
|
|||||